New rapid test for plague in the DRC
Part of Infections clinical trials.
This study is testing a new rapid test for plague, a serious infection. It aims to see if the test can quickly spot plague in people with symptoms, helping them get the right treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 5 years old or older.
- You live in the Rethy, Logo, or Aru health zones in the Democratic Republic of the Congo.
- You have symptoms that could be plague (like a swollen, painful lymph node or fever with cough and chest pain).
- You are willing to give your consent (or have a parent give permission if you are under 18).
- You have not taken antibiotics in the last 2 days (48 hours) before joining the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors find meningitis (and rule it out) and improve screening and prevention in rural clinics. You might be included if you come to the clinic with symptoms that could be meningitis, or if you have HIV and are receiving care there.
This study looks for antibiotic-resistant bacteria in the blood of patients with a suspected bloodstream infection. The goal is to understand which antibiotics still work, helping doctors choose the right treatment.
This study is looking at how to better care for people with fever in the Democratic Republic of the Congo. If you have a fever now or very recently, you may be able to join and help doctors learn more about it.
This study checks how well a rapid measles blood test works by comparing it to the standard confirmatory tests used in Senegal. If you (or your child) might have measles, the results could help clinicians diagnose it faster and guide next steps.
This trial tests a rapid point-of-care test for syphilis in mothers and their newborns. It aims to find out if this test can help diagnose and treat syphilis faster, which could improve health outcomes for both mother and baby.
This study is testing a new rapid diagnostic test that aims to help eliminate onchocerciasis (river blindness). The test will be checked in people with different types of filarial worm infections (or no infection) to see how well it can tell them apart.
Hear when a new Plague trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.